永信 (3705.TW)

52.10 +0.30 (+0.58%) 市場開市。 截至 11:26AM CST。

永信

No. 1191, Zhongshan Road
Section 1 Dajia District
Taichung
Taiwan
886 2 2545 0185
https://www.yungshingroup.com

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Chih-Wei Chien	President	3.91M	無	無
Yu-Yi Lee	Financial Officer & Finance and Accounting Manager	無	無	無
Vic Chung	Director of IR Relation	無	無	無
I-Yun Wang	Chief Corporate Governance Officer	無	無	無
Zhi Chang Pan	Treasurer	無	無	無

截止 2021年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 TWD。

描述

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics in Taiwan, Mainland China, Japan, and the United States. It also engages in the extraction, manufacture, and sale of wood products; manufacture and sale of over-the-counter drugs, preparations, and chemical intermediates; and pharmaceutical research, transfer, and authorization services, as well as import and export trading. In addition, the company is involved in the trading, wholesale, and retail of health products, cosmetics, medicines, human testing reagents, and the aforesaid related raw materials; semi-finished products; and production equipment. YungShin Global Holding Corporation was founded in 1952 and is based in Taichung, Taiwan.

公司管治

截至 無 止，永信 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。